Ticker Details
Gossamer Bio, Inc.
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$85.55M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.16%
Avg Daily Range (30 D):	$0.01 | 6.43%
Avg Daily Range (90 D):	$0.02 | 6.15%

Institutional Daily Volume
Avg Daily Volume:	2.12M
Avg Daily Volume (30 D):	14.73M
Avg Daily Volume (90 D):	11.86M

Trade Size
Avg Trade Size (Sh.):	264
Avg Trade Size (Sh.) (30 D):	607
Avg Trade Size (Sh.) (90 D):	557

Institutional Trades
Total Institutional Trades:	1,352
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$1.88M
Avg Institutional Trade (90 D):	$2.11M
Avg Institutional Trade Volume:	.31M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.71M
Avg Closing Trade (30 D):	$3.27M
Avg Closing Trade (90 D):	$3.32M
Avg Closing Volume:	384.33K

News

May 31, 2026 @ 10:59 PM GOSS Investors Have Opportunity to Lead Gossamer B... Source: The Schall Law Firm

May 31, 2026 @ 9:43 PM GOSS FINAL DEADLINE ALERT: Gossamer Bio Investors ... Source: Hagens Berman

May 30, 2026 @ 10:52 PM GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR C... Source: Rosen Law Firm

May 29, 2026 @ 6:48 PM Gossamer Bio, Inc. (GOSS) Faces Securities Class A... Source: Hagens Berman

May 29, 2026 @ 4:52 PM GOSSAMER BIO DEADLINE MONDAY JUNE 1st: Bragar Eage... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS		$-.2	$-.21
Diluted EPS		$-.2	$-.21
Revenue		$16.96M	$13.29M
Gross Profit
Net Income / Loss		$-46.66M	$-48.22M
Operating Income / Loss		$-44.87M	$-49.11M
Cost of Revenue
Net Cash Flow		$3.4M	$-17.28M
PE Ratio